The Dermisgraft Epithelialization and Late Scar Healing

Sponsor
University Hospital, Linkoeping (Other)
Overall Status
Completed
CT.gov ID
NCT05189743
Collaborator
(none)
23
1
2
48
0.5

Study Details

Study Description

Brief Summary

Study Synopsis

Title; The dermis graft: epithelialization and late scar evaluation A Clinical Prospective multicenter trial

Objectives; The objective of this study is to compare a dermal graft with a conventional split thickness skin graft regarding healing quality and scarring.

Design; the study is a prospective, controlled clinical multicenter trial.

Study population; Atleast 20 burn patients (18-80 years) with a full thickness burn that requires permanent skin cover.

Time plan; Enrollment will continue until atleast 20 patients have been included and completed the study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Skin transplantation to heal burn injuries
N/A

Detailed Description

Background: Donor site morbidity is a major concern such as wound healing disturbances, hypertrophic scarring and hypo-/hyperpigmentation. The dermal graft technique is an alternative to the standard split-thickness skin graft (STSG) technique to minimize donor site morbidity. Immediate cover of the donor site after harvest leaving a non-exposed wound is a big advantage. The aim of the study was to compare the functional and aesthetic outcome between two treatment methods (dermal graft with STSG).

Methods: From February 2017 to December 2020, 21 patients received a dermis graft and a regular split-thickness skin graft in a prospective randomized study design. The recipient and the donor site were compared separately regarding healing time, scarring and patient subjective satisfaction. All sites (both donor and recipient) were analyzed histologically regarding remodeling and scar formation.

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Prospective Multi-centre Randomised Study for Treatment of Burns With Dermis Graft or Split-thickness Skin Auto-graft.
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Jan 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dermis graft

Procedure: Skin transplantation to heal burn injuries
The study compare two different treatment modalities, STSG (split-thickness skin graft) versus dermis graft after excision of devitalized/necrotic tissue. A dermatome will be used for graft harvest.

Experimental: STSG

Procedure: Skin transplantation to heal burn injuries
The study compare two different treatment modalities, STSG (split-thickness skin graft) versus dermis graft after excision of devitalized/necrotic tissue. A dermatome will be used for graft harvest.

Outcome Measures

Primary Outcome Measures

  1. Healing time [4 weeks]

    Recipient sites are to be assessed regarding healing (re-epithelization) at each site (donor respective recipient). Healing will be assesed in days after surgery.

  2. Aesthetic outcome [12 months]

    The aesthetic appereance regarding scarring will be assessed. A MPA580 cutometer will asses the viscoelasticity in the skin and POSAS will asses the appereance of the scar objectively as subjectively. R0 and R2 will be used as variables evaluating firmness and elasticity. POSAS will be analysed accoring to a scoring system (0-10 and 0-60).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Thermal & chemical burns < 30 % TBSA

  • Males & females between 18-80 years old

  • At least one coherent full thickness wound measuring 15 x 7.5 cm

  • A minimal of 15 x 7.5 cm coherent undamaged skin located at frontal or lateral side of one of the thighs for graft harvest.

Exclusion Criteria:
  • Patients with severe cutaneous trauma at the same site as the burn injury

  • Previous burns at the treatment site

  • Severe cognitive dysfunction or psychiatric disorder

  • Chronic skin disorder

  • Chronic use of systemic or local corticosteroid

  • Chronic use of anticoagulants or platelets

  • Autoimmune disease

  • Active hepatitis

  • Full thickness burns of head, genitalia, axilla or upper third of medial upper arm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Linköpings Unversity Hospital Linköping Sweden

Sponsors and Collaborators

  • University Hospital, Linkoeping

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Folke Sjoberg, Professor, University Hospital, Linkoeping
ClinicalTrials.gov Identifier:
NCT05189743
Other Study ID Numbers:
  • 2.4
First Posted:
Jan 12, 2022
Last Update Posted:
Jan 12, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 12, 2022